Tag: QURE

Blue Horseshoe Stocks: QURE Recap & More

uniQure N.V. QURE

We included QURE in our premarket report on Thursday, after the company’s hemophilia gene therapy treatment was advanced to Phase III testing.

What followed was an enormous influx of volume, and two really solid, bullish sessions, advancing from a low of 11.55 on Thursday to a new high of 19.34 on Friday. That works out to a very respectable two-day swing of 67%

It’s the highest PPS QURE has attained since 2015, and the two sessions come in at numbers 1 and 2 highest volume days of all time, so we’d say our alert was timed with absolute precision.

Organovo Holdings, Inc. ONVO

We included ONVO in Friday morning’s extended watchlist, and it also put up a pretty good performance on the day.

From a low of 1.45, the stock traded as high as 1.80 on fairly heavy volume. We’ll want to see the stock continue to establish higher highs and higher lows as it’s coming off of its bottom.

PetMed Express, Inc. PETS

We’d like to signal a post-earnings options idea for PETS this morning, after the company set new records with its Q2 numbers. It’s gapping up significantly in the premarket, and the volume it traded on Friday leading into the release was the highest all month.  We’re going to put the PETS 11/17 $40-50 Calls on watch moving forward.

Extended Watchlist:
TISA, IMNP, LBIX, GEVO, KALV, ATNM, ATOS, XNET

Blue Horseshoe Stocks: Updates, Options & More

First thing’s first- we have a few of updates from our premarket report on Tuesday, that we held over until today in favor of the Special Report which we published yesterday.

Neothetics, Inc. NEOT

One of the real standouts from our premarket report on Tuesday morning turned out to be NEOT, which stair-stepped its way steadily up the chart all day long.

From its low of .83, the stock traded up as high as 1.99, which worked out to an intraday increase of 140% and the move occurred on extremely high volume, to the tune of more than 85X the monthly average.

Yesterday, NEOT transitioned into consolidation mode off of that impressive high, so we’ll be monitoring it for support, because the recent volatility suggests that a significant rebound could ensue.

 TransEnterix, Inc. TRXC

We caught TRXC on Monday after it was reported that the company’s robotic surgery device got regulatory approval. The result was a very nice run from a low of  2.15 to 3.05 (+42%) on that day. Tuesday, we mentioned that we’d be on the lookout for further gains, and the stock did go on to hit new highs.

Tuesday TRXC ran from 3.28 all the way up to an even 5.00, an intraday gain of 52% and an overall increase of 133% from our observed low at the beginning of this week.

Yesterday, much like NEOT, TRXC began to pull back, and so we’ll also want to continuie watching this one for a potential dip-and-rip type formation.

Firefish, Inc. FRFS – Chatroom Call

FRFS was .0047 when we alerted it our trader’s chatroom on Tuesday morning. As of yesterday’s high of .077, we had witnessed a mind-blowing two-day swing of 1538% With the kind of price action and volatility we’ve seen exhibited by FRFS in the past two days, we’ll definitely want to keep our eyes peeled for further activity.

This play is another good example of why we encourage our members to get involved with this aspect of our daily activities. Ideas that come to us after 9AM Eastern don’t make it into our premarket reports, so the chats are your way to keep up with what’s moving in real time.

These Skype-based live chats are open to any of our readers. Just send a contact request to the username “stocksumo”.

Ulta Beauty, Inc ULTA – Options Idea

We’re looking at ULTA as a potential recovery play into the holiday season, as the stock just bounced off of a new annual low this week. Last week, a huge block of insider buying came in, on the order of more than $21M.

For some extended-term recovery ideas, we’re going to signal  and track the ULTA 12/01 $202.50-212.50 Calls and the 12/15 $210-225 Calls.

Extended Watchlist:
ADHD, ARNA, JAGX, MTBC LLNW, RGSE, PTN, QURE

Blue Horseshoe Stocks: EBIO, HRB Updates & More

H&R Block, Inc. HRB – Options Update

The options idea we formulated and passed along to our readers on Friday for HRB was far away our best play of the week, and an excellent way to wrap it up. Our specific target range that we highlighted in this case was the HRB 06/17 $21-23 Calls. and we ended up seeing monstrous moves out of each of the contained contracts.

$21 Calls – Trading Range: .60-3.30 – Max Gain: 450%
$22 Calls – Trading Range: .15-2.30 – Max Gain: 1430%
$23 Calls– Trading Range: .05-1.30 – Max Gain: 2500%

______

Added Reminder:

The other options play we set our sights on in Friday morning’s report was Global Blood Therapeutics,Inc. GBT – 06/17 $20-30 Calls. We saw some moderate activity as the stock ran early in the day, before tapering off. As they don’t expire until the end of this week, we just wanted to reiterate the possibility of more pronounced moves if GBT maintains support at 22.00 or above.

Eleven Biotherapeutics, Inc. EBIO 

The last time we reminded folks about our interest in EBIO, a stock that has appeared in our reports many times in the past, was on June 3rd. On that day, we were commenting on an earlier alert we put out on it back in May while EBIO’s PPS was at .80, after seeing it run up to its then-high of 2.10.

It ended up topping out at 2.60 on the afternoon of the 3rd, and has since been under light consolidation. It reached a support level of 1.62 on Friday, before beginning to rebound, and this morning it has gapped up hard in the premarket to a new high of 3.55 on the strength of an attractive PR (link below).

From our observed low in May, it represents an overall increase of 344% We’ll want to see the stock’s previous resistance level of 2.60 hold as support on any early pullbacks.

Extended Watchlist:
AROPQ, EXAD, TRQ, GIG, AMRS, QURE,
FLXN(Big Insider Buying)